z-logo
open-access-imgOpen Access
Analysis of cell cycle‐related Ki‐67 and p120 expression by flow cytometric BrdUrd‐Hoechst/7AAD and immunolabeling technique
Author(s) -
Endl Elmar,
Steinbach Pia,
Knüchel Ruth,
Hofstädter Ferdinand
Publication year - 1997
Publication title -
cytometry
Language(s) - English
Resource type - Journals
eISSN - 1097-0320
pISSN - 0196-4763
DOI - 10.1002/(sici)1097-0320(19971101)29:3<233::aid-cyto6>3.0.co;2-c
Subject(s) - flow cytometry , cell cycle , staining , biology , microbiology and biotechnology , bromodeoxyuridine , antigen , immunofluorescence , mitosis , immunolabeling , cell , cell growth , cell culture , antibody , immunohistochemistry , immunology , biochemistry , genetics
Flow cytometric multiparameter analysis of two proliferation associated antigens, Ki‐67 and p120, was combined with cell cycle kinetic analysis, achieved by continuous labeling with 5‐Bromodeoxyuridine (BrdUrd), followed by staining with Hoechst 33258 and 7‐Aminoactinomycin D (7AAD). Exponential and plateau phase monolayer cultures of the human bladder carcinoma cell line J82 were examined. Resting cells, characterized by their absent BrdUrd incorporation, showed no reactivity with the MIB1 antibody, which was used for the detection of the Ki‐67 antigen. Proliferating cells revealed a cell cycle phase dependent Ki‐67 staining intensity, which was partially related to the time period spent in G1 after mitosis. In contrast to the Ki‐67 antigen expression, no decrease in p120 immunofluorescence staining intensity of non‐cycling cells could be observed. We could demonstrate that a dissection of the history of cell replication, obtained by the BrdUrd/Hoechst technique combined with a simultaneous immunofluorescence staining reveals detailed information, on a single cell level, about time dependent expression of proliferation associated antigens in all cell cycle compartments. Cytometry 29:233–241, 1997. © 1997 Wiley‐Liss, Inc.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here